De Santis, R. (2006). Low and High Tenascin-Expressing Tumors Are Efficiently Targeted by ST2146 Monoclonal Antibody. Clinical Cancer Research, 12(7), 2191–2196.
doi:10.1158/1078-0432.CCR-05-2526
url to share this paper:
An interview with Sci-Hub Founder Alexandra Elbakyan Who exactly should pay for academic research